Looking Ahead and Advice for Newly Diagnosed Patients

In the final episode of this CURE Connections program, Michael Goldman reflects on how tumor-infiltrating lymphocyte (TIL) therapy changed his outlook, describing it as receiving "a new cancer-fighting immune system" and a renewed commitment to healthy living. He offers heartfelt advice for anyone newly diagnosed with stage 3 or stage 4 melanoma, encouraging them to listen to their care team, focus on what they can control, and remember that every day they extend their life is another chance for the next advancement to arrive. Medical oncologist James Smithy, MD, MHS, of Memorial Sloan Kettering Cancer Center, and acute care nurse practitioner Mary Montefusco, ACNP, close out the program with guidance on the value of seeking care at specialized cancer centers, where the full team's experience in melanoma and cellular therapy translates into continuity, access to clinical trials, and personalized follow-up.